Sponsor Pipeline

Tango Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
5
Disease Areas
Active Trials by Phase
Phase 1/2
4
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06810544 Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients… Non Small Cell Lung Cancer Recruiting
NCT05732831 Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors Locally Advanced Solid Tumor Recruiting
NCT06922591 Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC &… PDAC Recruiting
NCT05887492 Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors Non Small Cell Lung Cancer Active, Not Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (3) Lung Cancer (3) Glioblastoma (1) Glioma (1) Pancreatic Cancer (1)
Get alerts when Tango Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free